Avenue Therapeutics (NASDAQ:ATXI) Shares Set to Reverse Split on Friday, April 26th

Avenue Therapeutics, Inc. (NASDAQ:ATXI) shares are set to reverse split before the market opens on Friday, April 26th. The 1-75 reverse split was announced on Friday, April 26th. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, April 26th.

Avenue Therapeutics Stock Down 29.6 %

NASDAQ ATXI traded down $0.04 during trading on Wednesday, hitting $0.09. The company’s stock had a trading volume of 12,284,611 shares, compared to its average volume of 4,543,282. The firm has a 50 day moving average price of $0.15 and a 200 day moving average price of $0.21. The firm has a market cap of $4.17 million, a P/E ratio of -0.07 and a beta of -0.24. Avenue Therapeutics has a 52 week low of $0.09 and a 52 week high of $1.25.

Avenue Therapeutics (NASDAQ:ATXI) last issued its quarterly earnings results on Monday, March 18th. The company reported $0.56 EPS for the quarter.

Avenue Therapeutics Company Profile

Avenue Therapeutics, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders.